Annual Working Capital
$246.60 M
-$134.46 M-35.28%
December 31, 2021
Summary
- As of February 10, 2025, SBTX annual working capital is $246.60 million, with the most recent change of -$134.46 million (-35.28%) on December 31, 2021.
- During the last 3 years, SBTX annual working capital has risen by +$230.97 million (+1477.33%).
Performance
SBTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$266.81 M
+$14.82 M+5.88%
September 30, 2022
Summary
- As of February 10, 2025, SBTX quarterly working capital is $266.81 million, with the most recent change of +$14.82 million (+5.88%) on September 30, 2022.
- Over the past year, SBTX quarterly working capital has dropped by -$23.20 million (-8.00%).
Performance
SBTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SBTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | -8.0% |
| 3 y3 years | +1477.3% | +3706.5% |
| 5 y5 years | +1477.3% | +3706.5% |
SBTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -7.6% |
| 5 y | 5-year | -35.3% | -103.0% | -30.0% | -102.8% |
| alltime | all time | -35.3% | -103.0% | -30.0% | -102.8% |
Silverback Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $266.81 M(+5.9%) |
| Jun 2022 | - | $251.99 M(+2.2%) |
| Mar 2022 | - | $246.52 M(-0.0%) |
| Dec 2021 | $246.60 M | $246.60 M(-15.0%) |
| Sep 2021 | - | $290.01 M(-16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $347.48 M(-5.3%) |
| Mar 2021 | - | $366.75 M(-3.8%) |
| Dec 2020 | $381.06 M(-5250.8%) | $381.06 M(+181.9%) |
| Sep 2020 | - | $135.18 M(-1927.2%) |
| Dec 2019 | -$7.40 M(-147.3%) | -$7.40 M |
| Dec 2018 | $15.63 M | - |
FAQ
- What is Silverback Therapeutics annual working capital?
- What is the all time high annual working capital for Silverback Therapeutics?
- What is Silverback Therapeutics annual working capital year-on-year change?
- What is Silverback Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Silverback Therapeutics?
- What is Silverback Therapeutics quarterly working capital year-on-year change?
What is Silverback Therapeutics annual working capital?
The current annual working capital of SBTX is $246.60 M
What is the all time high annual working capital for Silverback Therapeutics?
Silverback Therapeutics all-time high annual working capital is $381.06 M
What is Silverback Therapeutics annual working capital year-on-year change?
Over the past year, SBTX annual working capital has changed by -$134.46 M (-35.28%)
What is Silverback Therapeutics quarterly working capital?
The current quarterly working capital of SBTX is $266.81 M
What is the all time high quarterly working capital for Silverback Therapeutics?
Silverback Therapeutics all-time high quarterly working capital is $381.06 M
What is Silverback Therapeutics quarterly working capital year-on-year change?
Over the past year, SBTX quarterly working capital has changed by -$23.20 M (-8.00%)